Psoriasis Meds May Reduce Heart Disease Risk, Study Suggests
Psoriasis Meds May Reduce Heart Disease Risk, Study Suggests
A new study has found that using drugs like adalimumab and ustekinumab might lower levels of a dangerous type of coronary disease.
According to a study published in the September 2020 issue of the journal Circulation: Cardiovascular Imaging, individuals who received biologics like adalimumab and ustekinumab for one year to manage their psoriasis had lower levels of a type of coronary plaque…
View On WordPress















